Search Results - "Petershofen, Eduard K"

Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial by Brixner, Veronika, Bug, Gesine, Pohler, Petra, Krämer, Doris, Metzner, Bernd, Voss, Andreas, Casper, Jochen, Ritter, Ulrich, Klein, Stefan, Alakel, Nael, Peceny, Rudolf, Derigs, Hans G, Stegelmann, Frank, Wolf, Martin, Schrezenmeier, Hubert, Thiele, Thomas, Seifried, Erhard, Kapels, Hans-Hermann, Döscher, Andrea, Petershofen, Eduard K, Müller, Thomas H, Seltsam, Axel

“…Pathogen reduction (PR) technologies for blood components have been established to reduce the residual risk of known and emerging infectious agents. THERAFLEX…”
Get full text

Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study by Gassner, Christoph, Doescher, Andrea, Drnovsek, Tadeja Dovc, Rozman, Primoz, Eicher, Nicole I., Legler, Tobias J., Lukin, Sergey, Garritsen, Henk, Kleinrath, Thomas, Egger, Bernd, Ehling, Rainer, Körmöczi, Günther F., Kilga-Nogler, Susanne, Schoenitzer, Diether, Petershofen, Eduard K.

“…BACKGROUND: RHD blood group alleles with reduced or absent antigen expression are a clinically significant and heterogeneous group. Study design and methods:…”
Get full text

In-frame triplet deletions in RHD alter the D antigen phenotype by Flegel, Willy A., Eicher, Nicole I., Doescher, Andrea, Hustinx, Hein, Gowland, Peter, Mansouri Taleghani, Behrouz, Petershofen, Eduard K., Bauerfeind, Ursula, Ernst, Manfred, Von Zabern, Ingeborg, Schrezenmeier, Hubert, Wagner, Franz F.

“…BACKGROUND: The deletion of three adjacent nucleotides in an exon may cause the lack of a single amino acid, while the protein sequence remains otherwise…”
Get full text

Platelet engraftment after allogenic stem cell transplantation is monitored by digital polymerase chain reaction without interference by platelet support by Doescher, Andrea, Casper, Jochen, Kraemer, Doris, Kapels, Hans-Hermann, Petershofen, Eduard K., Müller, Thomas H.

“…•Cutoff value for quantification of platelets with digital polymerase chain reaction (ddPCR) was 1 platelet/nL.•Engraftment as determined by ddPCR was earlier…”
Get full text

Herpes zoster prophylaxis with low‐dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation by Abbasov, Emin, Metzner, Bernd, Müller, Thomas H., Casper, Jochen, Kimmich, Christoph, Petershofen, Eduard K., Renzelmann, Andrea, Rosien, Bernd, Thole, Ruth, Voß, Andreas, Köhne, Claus Henning

“…Background Herpes zoster (HZ) is a frequent complication after autologous stem cell transplantation (ASCT). The option of zoster prophylaxis with an antiviral…”
Get full text

Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous stem cell transplantation by Metzner, Bernd, Pott, Christiane, Müller, Thomas H., Casper, Jochen, Kimmich, Christoph, Petershofen, Eduard K., Renzelmann, Andrea, Rosien, Bernd, Thole, Ruth, Voß, Andreas, Köhne, Claus Henning, Wellnitz, Dominique

“…Objective To contribute data on long‐term outcome and potential curative impact of ASCT in FL, especially following HDT with the BEAM protocol (BCNU,…”
Get full text

Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual disease by Metzner, Bernd, Welzel, Jutta, Müller, Thomas H., Casper, Jochen, Kimmich, Christoph, Petershofen, Eduard K., Renzelmann, Andrea, Rosien, Bernd, Thole, Ruth, Voss, Andreas, Willborn, Kay, Köhne, Claus Henning

“…Purpose The prognosis of an early relapse of diffuse large B-cell lymphoma (DLBCL) appears to be poor following autologous stem cell transplantation (ASCT)…”
Get full text

Digital PCR to assess platelet recovery after stem cell transplantation by Doescher, Andrea, Casper, Jochen, Kraemer, Doris, Kapels, Hans-Hermann, Petershofen, Eduard K, Müller, Thomas H.

Get full text

Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups by Doescher, Andrea, Petershofen, Eduard K., Wagner, Franz F., Schunter, Markus, Müller, Thomas H.

“…BACKGROUND: Determination of fetal blood groups in maternal plasma samples critically depends on adequate amplification of fetal DNA. We evaluated the routine…”
Get full text

Platelet recovery and survival measured in patients by quantitative polymerase chain reaction of mitochondrial DNA by Doescher, Andrea, Petershofen, Eduard K., Hertenstein, Bernd, Kraemer, Doris, Casper, Jochen, Schmidt, Jörg-Peter, Müller, Thomas H.

“…Background Mitochondrial (mt) DNA markers have been identified as potential targets for the quantification of endogenous and allogeneic platelets (PLTs) in the…”
Get full text

Cost-efficient sequence-specific priming-polymerase chain reaction screening for blood donors with rare phenotypes by Wagner, Franz F., Bittner, Rita, Petershofen, Eduard K., Doescher, Andrea, Müller, Thomas H.

“…BACKGROUND: Transfusion support for patients with irregular antibodies to red blood cell (RBC) antigens of high frequency may be hampered by lack of…”
Get full text

The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies by Adamczyk, Thomasz, Doescher, Andrea, Haydock, Paul V., Aldrich, Russ, Petershofen, Eduard K., Müller, Thomas H.

“…Background: Determination of fetal blood groups in maternal plasma samples critically depends on adequate pre-analytical steps for optimal amplification of…”
Get full text

RHCE alleles detected after weak and/or discrepant results in automated Rh blood grouping of blood donors in Northern Germany by Döscher, Andrea, Vogt, Claudia, Bittner, Rita, Gerdes, Ingrid, Petershofen, Eduard K., Wagner, Franz F.

“…BACKGROUND: More than 170 weak or partial RHD alleles are currently known. A similar heterogeneity of RHCE alleles may be anticipated, but a large‐scale…”
Get full text

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl–positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571) by Scheuring, Urban J., Pfeifer, Heike, Wassmann, Barbara, Brück, Patrick, Atta, Johannes, Petershofen, Eduard K., Gehrke, Brigitte, Gschaidmeier, Harald, Hoelzer, Dieter, Ottmann, Oliver G.

“…The Abl kinase inhibitor imatinib mesylate (STI571) has significant and rapid antileukemic activity in Philadelphia chromosome/Bcr-Abl–positive acute…”
Get full text

Weak D type 1.1 exemplifies another complexity in weak D genotyping by Doescher, Andrea, Flegel, Willy A., Petershofen, Eduard K., Bauerfeind, Ursula, Wagner, Franz F.

“…BACKGROUND: Weak D expression is caused by a large number of RHD alleles. Increasingly recommendations for D+ or D– transfusions are based on polymerase chain…”
Get full text

Long-Term Clinical and Molecular Remissions in Patients with Mantle Cell Lymphoma (MCL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) by Metzner, Bernd, Casper, Jochen, Claus-Henning, Koehne, Renzelmann, Andrea, Mueller, Thomas H., Petershofen, Eduard K., Rosien, Bernd, Thole, Ruth, Voss, Andreas, Dreyling, Martin H., Hoster, Eva, Klapper, Wolfram, Pott, Christiane

“…Background:Long-term clinical and molecular remissions in patients with MCL following HDT and ASCT have been evaluated in only a few studies. Results are…”
Get full text